Clinical Trials
258 trialsFluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
Roswell Park Cancer Institute
Multimodal AI for Precision Diagnosis of Esophageal Cancer
Shanghai Zhongshan Hospital
A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors
Henan Cancer Hospital
DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
Tianjin Medical University Cancer Institute and Hospital
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
National Cancer Institute (NCI)
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Eastern Cooperative Oncology Group
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
M.D. Anderson Cancer Center
an AI-Driven Four-Tier Invasion Depth Classification for Early Esophageal Cancer
Fudan University
REGINA
Jules Bordet Institute
HDL-CEUS-MRI
The First Hospital of Jilin University
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
OMEC-5
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Cedars-Sinai Medical Center
Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Shandong Cancer Hospital and Institute
CRITⅡ
Sixth Affiliated Hospital, Sun Yat-sen University
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction
Xijing Hospital
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
Nanfang Hospital, Southern Medical University
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
University of Chicago
Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)
Institut de Cancérologie de Lorraine
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
First Affiliated Hospital of Zhejiang University
Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer
Ohio State University Comprehensive Cancer Center
FOBEAR
Sun Yat-sen University
Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer
First Affiliated Hospital of Zhejiang University
A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
Vaccinogen Inc
Neoadjuvant Treatment Modalities in Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
ROSETTE
Shanghai Zhongshan Hospital
ILDR-03
Shantou University Medical College
HORIZON
Mayo Clinic
SURGIGAST
University Hospital, Lille
KARCHER-1
University Hospital, Lille
Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy
Fujian Provincial Hospital
PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy
University of Southern California
ETHOS
Norwegian Department of Health and Social Affairs
FOLFIRINOX + NIS793 in Pancreatic Cancer
Massachusetts General Hospital
PRISM
Weill Medical College of Cornell University
A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST
Shanghai Zhongshan Hospital
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Massachusetts General Hospital
SIB-NCRT-pumch
Peking Union Medical College Hospital
EBPS
Fudan University
Rectal Cancer CTC Trial
University Hospital Ostrava
Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer
First Affiliated Hospital of Guangxi Medical University
SPN
Fudan University
STAR
Zhejiang Cancer Hospital
CB1 - CONTRACT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
SIROCHO
Center Eugene Marquis
Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery
Fujian Cancer Hospital
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
City of Hope Medical Center
AGAMENON
Fundación Sociedad Española de Oncologia Médica
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Medical College of Wisconsin